More related to the topic, here are some ways the drug companies can misinform prescribers.
Abbott did a talk about antibiotic resistance in respiratory illness. The talk focused on how their main competitor azithromycin increased resistance much more rapidly than Biaxin, which was theirs. Also, they discussed how Biaxin's coverage covered the bacteria that cause Sinus infections much better than azithromycin.
What they missed talking about was the fact that acute sinus infections are rarely bacterial, and as such should not be treated with antibiotics at all.
|